Share
Journal Information
Most often read
4880
Strategies for prevention and treatment of SARS-COV-2 infection in patients with chronic kidney disease: Literature reviewMaría Marques Vidas, Elena Muñez Rubio, Borja Quiroga, Rocío Montejano, Enrique Morales, Francisco Javier Candel
Nefrologia (English Version). 2024;44:150-8
4880
4072
Eliminating the concept of unknown chronic kidney disease: 2 cases of autosomal dominant tubulointerstitial nephropathy with pathogenic variant MUC-1Verónica Andreina Barcia Odor, Elena Monfá, Benjamin de León, Catherine Martinez-Rosero, Silvia Sanchez-Montero, Carmen Barnes, Cristina Lucas, Arancha Sastre, ... Mario Prieto
Nefrologia (English Version). 2024;44:105-7
4072
3784
Tixagevimab-cilgavimab como tratamiento profiláctico preexposición frente a SARS-CoV-2 en pacientes trasplantados renalesLuis Bravo González-Blas, Natalia Menéndez García, María Fernández Prada, María Gago Fraile, María Luisa Suárez Fernández, Natalia Ridao Cano
Nefrologia (English Version). 2024;44:396-401
3784
3494
Effect of SGLT2 inhibitors on anemia and their possible clinical implicationsAleix Cases, Secundino Cigarrán, José Luis Górriz, Julio Nuñez
Nefrologia (English Version). 2024;44:165-72
3494
3385
RIPK3 and kidney diseaseJuan Guerrero-Mauvecin, Miguel Fontecha-Barriuso, Ana M. López-Diaz, Alberto Ortiz, Ana B. Sanz
Nefrologia (English Version). 2024;44:10-22
3385
3360
De novo IgA nephropathy in a kidney transplant recipient after SARS-CoV-2 vaccinationM. Alonso, F. Villanego, Ó. Segurado, L.A. Vigara, C. Orellana, T. García, A. Mazuecos
Nefrologia (English Version). 2024;44:277-9
3360
3042
Targeting colonic BK channels: A novel therapeutic strategy against hyperkalemia in chronic kidney diseaseItsuro Kazama, Michiko Shoji
Nefrologia (English Version). 2024;44:594-6
3042
2913
COVID 19 and myoclonus, do hemodialysis patients have more risk?Salia Virxinia Pol Heres, Nuria Aresté Fosalba, Ana Barragán-Prieto, Wenceslao Adrián Aguilera Morales, Mercedes Salgueira
Nefrologia (English Version). 2024;44:284-6
2913
2910
I’m a Nephrologist and I give urea to my patients. SIAD in oncological patientsCíria Sousa, Inês Coelho, Hugo Ferreira, Teresa Chuva, Ana Paiva, José Maximino Costa
Nefrologia (English Version). 2024;44:115-8
2910
2880
Targeting metabolic-associated fatty liver disease in diabetic kidney disease: A call to actionSalvador Benlloch, Francesc Moncho, Jose Luis Górriz
Nefrologia (English Version). 2024;44:129-38
2880
2800
Acute kidney injury (AKI): Spanish nomenclature also matters hereJordi Bover, Gregorio Romero-González, Jonathan Samuel Chávez-Iñiguez, Lilia Rizo-Topete, Fredzzia Graterol, Anna Vila Santandreu, Maya Sanchez-Baya, Joan Manel Díaz, ... Esteban Poch
Nefrologia (English Version). 2024;44:113-5
2800
2771
Hypochloremia associated with a greater incidence of pneumonia in chronic hemodialysis patients with COVID-19: a center's experienceFrancisco Valga, Tania Monzón, Nicanor Vega-Diaz, Sergio Ruiz-Santana, Sara Aladro, Rassoul Diallo-Saavedra, Jose Carlos De la Flor, José Carlos Rodriguez-Perez
Nefrologia (English Version). 2024;44:290-2
2771
2717
Online hemodiafiltration without calcium replacement using citrate as an anticoagulant and dialysis fluid with 3.5 mEq of post dilutional calcium in patients with heparin-induced thrombocytopenia: Report of 2 casesLucas Ramos, Rosario Luxardo, María Soledad Crucelegui, Nadia Satera, Yuliana Jordán Ordoñez, Guillermo Rosa-Diez
Nefrologia (English Version). 2024;44:299-301
2717
2613
Dysregulation of ferroptosis may participate in the mitigating effect of CoCl2 on contrast-induced nephropathyHuilin Li, Shuang Liu, Dan Zhang, Xue Zong, Gengru Jiang, Chun Zhu
Nefrologia (English Version). 2024;44:180-93
2613
2544
Including KDIGO cardiovascular risk stratification into SCORE scale could improve the accuracy to better stratify cardiovascular riskAna Cebrian, Carlos Escobar, Unai Aranda, Beatriz Palacios, Margarita Capel, Antoni Sicras, Aram Sicras, Antonio Hormigo, ... Roberto Alcázar
Nefrologia (English Version). 2024;44:292-4
2544
2543
Acute interstitial nephritis following COVID-19 vaccinationAmnuay Kleebayoon, Viroj Wiwanitkit
Nefrologia (English Version). 2024;44:312
2543
2438
Decision making – Should we perform kidney transplantation on a patient with a positive RT-PCR test for SARS-CoV-2?Diogo Francisco, Gonçalo ÿvila, Cristina Jorge, Kamal Mansinho, Cristina Toscano, André Weigert
Nefrologia (English Version). 2024;44:297-9
2438
2431
β1-Integrin blockade prevents podocyte injury in experimental models of minimal change diseaseGabriel Cara-Fuentes, Rakesh Verma, Madhusudan Venkatareddy, Colin Bauer, Federica Piani, Sogut Turkmen Aksoy, Neha Vazzalwar, Gabriela E. Garcia, ... Puneet Garg
Nefrologia (English Version). 2024;44:90-9
2431
2368
Septic acute kidney injury and gut microbiome: Should we change our approach?Ioana Dicu-Andreescu, Mircea Niculae Penescu, Constantin Verzan
Nefrologia (English Version). 2024;44:119-28
2368
2302
Is just enzyme replacement therapy enough for Fabry disease treatment? Have we missed a trick?Hakan Ozer, Ismail Baloglu, Ali Topkac, Yasin Ozturk, Fethi Yonet, Furkan Daglı, İbrahim Kilinc, Kultigin Turkmen
Nefrologia (English Version). 2024;44:217-23
2302
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Nefrología
NEFROLOGÍA
AL DÍA
AL DÍA
